Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -909.50K | -942.70K | -787.60K | -1.51M | -726.10K |
| Total Depreciation and Amortization | 48.40K | 6.20K | 24.80K | 21.50K | 5.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.90K | 215.00K | 2.20K | 874.00K | 35.50K |
| Change in Net Operating Assets | 137.60K | 191.80K | 311.20K | 152.20K | 241.70K |
| Cash from Operations | -598.70K | -529.70K | -449.50K | -461.90K | -443.10K |
| Capital Expenditure | -28.60K | -14.10K | -1.60K | 0.00 | -3.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 73.40K | 222.80K | 147.20K |
| Cash from Investing | -28.60K | -14.10K | 71.80K | 222.80K | 143.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -75.00K | -50.00K | -- |
| Issuance of Common Stock | 1.13M | 1.64M | 677.20K | 1.07M | 688.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 1.13M | 1.64M | 602.20K | 1.02M | 688.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 500.70K | 1.10M | 224.50K | 780.20K | 388.50K |